Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Diginex Limited stock logo
DGNX
Diginex
$1.38
-2.1%
$1.38
$0.85
$318.84
$41.07M-2.81316,301 shs113,100 shs
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
$3.75
$3.75
$1.50
$4.84
$172.35M0.87N/AN/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$8.28
-2.5%
$8.33
$6.94
$18.05
$154.29M0.8394,752 shs133,259 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$2.68
+5.5%
$4.04
$2.11
$21.41
$134.62M-0.25375,436 shs670,431 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Diginex Limited stock logo
DGNX
Diginex
-2.13%+0.73%+9.52%+53.33%-98.35%
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
0.00%0.00%0.00%0.00%+85.64%
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
-2.59%+3.50%+1.22%-10.20%-51.78%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
+5.51%-12.70%-34.79%-83.98%-78.73%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Diginex Limited stock logo
DGNX
Diginex
$1.38
-2.1%
$1.38
$0.85
$318.84
$41.07M-2.81316,301 shs113,100 shs
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
$3.75
$3.75
$1.50
$4.84
$172.35M0.87N/AN/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$8.28
-2.5%
$8.33
$6.94
$18.05
$154.29M0.8394,752 shs133,259 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$2.68
+5.5%
$4.04
$2.11
$21.41
$134.62M-0.25375,436 shs670,431 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Diginex Limited stock logo
DGNX
Diginex
-2.13%+0.73%+9.52%+53.33%-98.35%
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
0.00%0.00%0.00%0.00%+85.64%
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
-2.59%+3.50%+1.22%-10.20%-51.78%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
+5.51%-12.70%-34.79%-83.98%-78.73%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Diginex Limited stock logo
DGNX
Diginex
1.00
SellN/AN/A
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
1.00
SellN/AN/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
2.00
HoldN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest DGNX, LAWR, TRAK, and ZSQR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/28/2026
Diginex Limited stock logo
DGNX
Diginex
Reiterated RatingSell (E+)
8/14/2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
DowngradeSell (D-)Sell (E-)
8/13/2026
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
UpgradeSell (D-)Sell (D)
7/31/2026
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
DowngradeHold (C)Hold (C-)
7/30/2026
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
UpgradeSell (E+)Sell (D-)
7/15/2026
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
UpgradeHold (C-)Hold (C)
7/13/2026
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
Reiterated RatingSell (E+)
(Data available from 9/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Diginex Limited stock logo
DGNX
Diginex
$3.62M11.10N/AN/A$0.70 per share1.97
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
$3.85M44.77N/AN/A($0.09) per share-41.67
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$22.61M6.65$0.44 per share18.71$2.71 per share3.06
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/AN/AN/AN/A$2.63 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Diginex Limited stock logo
DGNX
Diginex
-$31.15MN/AN/AN/AN/AN/AN/AN/AN/A
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
-$9.83MN/AN/AN/AN/AN/AN/AN/AN/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$6.98M$0.3722.38N/AN/A30.75%14.44%12.85%9/28/2026 (Confirmed)
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-$11.92M-$1.63N/AN/AN/A-773.72%-49.45%-46.88%N/A

Latest DGNX, LAWR, TRAK, and ZSQR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q4 2026
Diginex Limited stock logo
DGNX
Diginex
N/A-$0.48N/A-$0.48N/A$0.79 million
8/13/2026Q2 2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A-$0.28N/A-$0.28N/A$1.58 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Diginex Limited stock logo
DGNX
Diginex
N/AN/AN/AN/AN/A
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
N/AN/AN/AN/AN/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$0.080.97%N/A21.62%2 Years
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/AN/AN/AN/AN/A

Latest DGNX, LAWR, TRAK, and ZSQR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/18/2026
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
quarterly$0.020.97%9/30/20269/30/202611/13/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Diginex Limited stock logo
DGNX
Diginex
N/A
1.72
1.72
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
N/A
1.05
1.05
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
N/A
4.89
4.89
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A
7.66
7.66

Institutional Ownership

CompanyInstitutional Ownership
Diginex Limited stock logo
DGNX
Diginex
N/A
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
N/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
27.35%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
13.88%

Insider Ownership

CompanyInsider Ownership
Diginex Limited stock logo
DGNX
Diginex
N/A
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
N/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
41.00%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
24.25%
CompanyEmployeesShares OutstandingFree FloatOptionable
Diginex Limited stock logo
DGNX
Diginex
2129.13 millionN/AN/A
Robot Consulting Co., Ltd. stock logo
LAWR
Robot Consulting
1945.96 millionN/AN/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
6918.17 million10.72 millionN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
653.00 million40.15 millionNot Optionable

Recent News About These Companies

Coeptis Therapeutics (NASDAQ:ZSQR) Shares Down 2.9% - What's Next?
Z Squared Inc. Provides Capital Structure Update

New MarketBeat Followers Over Time

Media Sentiment Over Time

Diginex stock logo

Diginex NASDAQ:DGNX

$1.38 -0.03 (-2.13%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$1.42 +0.04 (+3.12%)
As of 09/18/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DSL is the wholly owned subsidiary of Diginex Limited. Accordingly, Diginex Limited owns 100% of DSL and all of DSL’s business lines and subsidiaries. DSL is an impact technology business that helps organizations to address the some of the most pressing Environmental, Social and Governance (“ESG”), climate and sustainability issues, utilizing blockchain, machine learning and data analysis technology to lead change and increase transparency in corporate social responsibility and climate action. Our products and services solutions enable companies to collect, evaluate and share sustainability data through easy-to-use software. DSL’s principal executive office is in Hong Kong where the CEO, CFO and CTO are based. The Hong Kong office is in a co-working shared space facility with 9 seats and the Hong Kong based employees operate under a hybrid model as they work both from the office and from home with the majority of working hours spent working from home. There is also an executive office in Monaco that is used by the Chairman and COO. DSL has subsidiaries in the United Kingdom and United States, however the subsidiary in the United States is inactive. DSL also outsources a component of IT development and maintenance support to engineers in Vietnam. DSL has built several accessible, affordable and intelligent products to help democratize sustainability and offers multiple supporting services to complement the product suite. DSL’s suite of products includes the following: digninexESG: is an accredited Hong Kong Monetary Authority award winning cloud based ESG platform that offers end to end reporting from topic discovery, data collection to collaborative report publishing. Our diginexESG platform is ISO-27001 Certified (an international standard to manage information security), official partner of Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB), World Economic Forum and signatory of the United Nations Principles of Responsible Investment (UN PRI). The diginexESG platform guides companies through the entire ESG journey; from materiality assessment & stakeholder engagement, framework & indicator selection, the data collection and collaboration process, report creation, validation and ultimately report publishing. By leveraging machine learning and data analytics, diginexESG is able to drive material efficiencies in the reporting process, and the blockchain-enabled audit trail, whereby a record of each data activity is created and stored on a blockchain, provides greater transparency in the data thus increasing its value. Originally targeted specially at Small and Medium Sized Enterprises (SMEs) around the world who are new to ESG reporting and lack the budget or bandwidth to engage with traditional and often expensive consultants, diginexESG has increased its feature set to include functionality that also targets larger companies with more complex organizational structures. diginexESG has also been adopted by global commercial banks like HSBC to help engage with their diverse customer base at scale. diginexLUMEN: allows companies to execute comprehensive supply chain risk assessments about working conditions within the supply chain. Supplier information is validated against worker feedback and automated risk calculations enables companies to prioritize issues for mitigation and prevention of adverse impacts and improvement efforts. diginexLUMEN focuses on broad data collection through complex inter-jurisdictional supply chains with a specific focus on social governance issues such as forced labor due diligence, gender risk and child labor risk. Through the collection of data from suppliers and validation by workers, diginexLUMEN relies on proprietary algorithms to generate risk scores to help companies identify which parts of their supply chain require greater scrutiny. The platform then auto-generates corrective action plans which allow the brands and suppliers to work together to remedy potentially problematic areas and reduce the risk score. diginexAPPRISE: is a multilingual application that collects standardized, actionable data related to working conditions directly from workers in global supply chains. Through tailored question sets, companies can deploy surveys directly to workers in their supply chain on a variety of topics such as responsible recruitment, gender equality and pulse check living and working conditions. The worker voice tool was initially developed by the United Nations University Institute in Macau (UNU-IIST) in partnership with The Mekong Club – an organization working with the private sector to bring about sustainable practices against modern slavery, and was acquired by DSL on December 14, 2021. diginexAPPRISE is available both as a standalone tool and also fully integrated into diginexLUMEN. diginexCLIMATE: is a proprietary carbon footprint calculator based on the GHG protocols that is currently available as an integrated part of the diginexESG platform. This allows companies to seamlessly calculate their Scope 1, 2 and 3 carbon footprint as part of their overall ESG reporting journey. Scope 1 are those direct emissions that are owned or controlled by a company, whereas scopes 2 and 3 indirect emissions are the result of the activities of the company but occur from sources not owned or controlled by it. DSL also offers the following complementary services: diginexADVISORY: is a service offered by DSL as a complement to the suite of DSL software license sales. diginexADVISORY provides clients strategy and advisory support at every stage of the sustainability journey, including assurance solutions for credible reporting. We also offer custom framework creation for clients who need more complex reporting templates or who want to set a benchmark for others in their industry. As part of diginexADVISORY we also develop and run one-off or programmatic training sessions covering a range of topics from a general introduction to ESG to complex carbon accounting and emissions. diginexPARTNERS: is a service whereby DSL develops white label versions of both diginexESG and diginexLUMEN for companies who then want to run either diginexESG or diginexLUMEN as an extension of their own service offering. This service often requires custom technology work up front for our clients that generates initial revenue as well as ongoing service and maintenance licenses which generate ongoing recurring revenue. In addition, DSL develops custom software platforms as part of a project consortiums for organizations like the United States Department of State, United States Department of Labor, and the United Nations. diginexMANAGEDSERVICES: is service to be offered by DSL to provide oversight and support to clients in operationalizing the roll out of our software products within their organizational structure or supplier base. This service can include training and education, onboarding, data collection and analysis, as well as general on-going support. We will be offering this kind of vertical integration as a service from 2024 onwards and expect it to become an important part of our overall product and service offering. Our global headquarters and principal executive office is located at Smart-Space Fintech 2, Room 3, Unit 401-404 Core C, Cyberport, Telegraph Bay, Hong Kong. We also have an office at Avenue des Papalins a Monaco portant le numero D2/D3, Monaco which was used by the Chairman and Chief Operating Officer. Our registered office in the Cayman Islands is located at the offices of Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands. Our agent for service of process in the United States is Puglisi & Associates, 850 Library Avenue, Suite 2-4, Newark, Delaware.

Robot Consulting stock logo

Robot Consulting NASDAQ:LAWR

$3.75 0.00 (0.00%)
As of 09/18/2026

Robot Consulting Co. Ltd. is a platform service provider focusing on human resource solutions with an intention to expand into legal technology and the metaverse. The Company's major product, Labor Robot, is a cloud-based human resource management system which helps users track employee attendance, manage sales orders and journalize accounting items. Robot Consulting Co. Ltd. is based in Tokyo, Japan.

ReposiTrak stock logo

ReposiTrak NYSE:TRAK

$8.28 -0.21 (-2.47%)
As of 09/18/2026 03:58 PM Eastern

Park City Group, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company is headquartered in Murray, Utah.

Coeptis Therapeutics stock logo

Coeptis Therapeutics NASDAQ:ZSQR

$2.68 +0.14 (+5.51%)
As of 09/18/2026 04:00 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.